Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,920Revenue (TTM) $M131Net Margin (%)-150.7Altman Z-Score-1.7
Enterprise Value $M2,810EPS (TTM) $-1.4Operating Margin %-120.2Piotroski F-Score2
P/E(ttm)--Beneish M-Score-4.3Pre-tax Margin (%)-150.1Higher ROA y-yN
Price/Book65.110-y EBITDA Growth Rate %--Quick Ratio4.7Cash flow > EarningsY
Price/Sales20.55-y EBITDA Growth Rate %-25.3Current Ratio4.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-39.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-3,881.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M155ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with NKTR

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

NKTR is held by these investors:

NKTR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Nicholson JohnSVP & COO 2017-06-07Sell101,700$19.24-2.18view
Thomsen Jillian B.SVP & Chief Accounting Officer 2017-05-16Sell2,651$19.55-3.73view
ROBIN HOWARD WPresident & CEO 2017-05-16Sell8,388$19.55-3.73view
Nicholson JohnSVP & COO 2017-05-16Sell3,146$19.55-3.73view
Labrucherie Gil MSVP & CFO 2017-05-16Sell3,179$19.55-3.73view
Hora ManinderSVP Pharma Dev & Mfg Ops 2017-05-16Sell2,959$19.55-3.73view
Gergel Ivan P.SVP & Chief Medical Officer 2017-05-16Sell1,450$19.55-3.73view
Doberstein Stephen KSVP & Chief Scientific Officer 2017-05-16Sell1,701$19.55-3.73view
CHESS ROBERTDirector 2017-05-15Sell5,000$19.79-4.9view
CHESS ROBERTDirector 2017-04-17Sell5,000$18.720.53view

Quarterly/Annual Reports about NKTR:

News about NKTR:

Articles On GuruFocus.com
Annaly Capital Management: Attractive 9.5% Dividend Yield, but Interest Rates Are a Major Risk Jun 25 2017 
Never a Better Time to Pile on Chipotle Jun 25 2017 
Boeing Takes Lead Over Airbus With $30 Billion Worth of Orders on Day 1 of Paris Air Show Jun 25 2017 
Berkshire Hathaway’s Recent Investment: Home Capital Group Jun 25 2017 
Stocks That Fell to 3-Year Lows in the Week of June 23 Jun 24 2017 
Weekly Top Insider Buys Highlight for the Week of June 23 Jun 24 2017 
ID Watchdog Announces Special and Annual General Meeting Date and Record Date Jun 23 2017 
Ironclad Performance Wear Postpones 2017 Annual Meeting of Stockholders Jun 23 2017 
Delta and Korean Air Create Leading trans-Pacific Joint Venture Jun 23 2017 
Harwood Feffer LLP Announces Investigation of EnerNOC, Inc. Jun 23 2017 

More From Other Websites
Nektar Therapeutics breached its 50 day moving average in a Bullish Manner : NKTR-US : June 22, 2017 Jun 22 2017
Nektar (NKTR) Stock Rallied Almost 50% This Year: Here's Why Jun 16 2017
ETFs with exposure to Nektar Therapeutics : June 9, 2017 Jun 09 2017
Nektar to Webcast Presentation at Jefferies 2017 Global Healthcare Conference in New York City Jun 06 2017
Nektar Presents New Clinical Data from Two Studies of NKTR-214, a CD122-Biased Agonist, at 2017... Jun 05 2017
Top Gainers in the Healthcare Sector: May 22–26, 2017 May 31 2017
Are Nektar's (NKTR) Key Drugs Set to Drive Growth in 2017? May 30 2017
New Research Collaboration between Nektar and Takeda to Explore Combination Cancer Therapy... May 22 2017
Bristol-Incyte Match Beats Dow's Merck In Combination Trials May 19 2017
Nektar Therapeutics breached its 50 day moving average in a Bearish Manner : NKTR-US : May 18, 2017 May 18 2017
Nektar Therapeutics Announces Data Presentations at ASCO 2017 May 18 2017
Edited Transcript of NKTR earnings conference call or presentation 9-May-17 9:00pm GMT May 15 2017
ETFs with exposure to Nektar Therapeutics : May 15, 2017 May 15 2017
Nektar to Webcast Presentation at UBS Global Healthcare Conference 2017 in New York May 15 2017
Nektar Therapeutics :NKTR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017 May 12 2017
Nektar Therapeutics (NKTR) Loss Wider Than Expected in Q1 May 11 2017
The Not-So-Subtle Reason Behind Nektar Therapeutics' 10% Pop May 10 2017
Nektar reports 1Q loss May 09 2017
Nektar Therapeutics Reports Financial Results for the First Quarter of 2017 May 09 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat